Page last updated: 2024-08-25

bromopyruvate and B16 Melanoma

bromopyruvate has been researched along with B16 Melanoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hasunuma, N; Kagaya, M; Manabe, M; Noguchi, N; Osada, SI; Ueki, S; Yamada, M	1

Other Studies

1 other study(ies) available for bromopyruvate and B16 Melanoma

Article	Year
Topical 3-bromopyruvate is a novel targeted therapy for melanoma in a preclinical model. Journal of dermatological science, 2018, Volume: 92, Issue:2 Topics: Administration, Cutaneous; Animals; Apoptosis; Cell Line, Tumor; Drug Evaluation, Preclinical; Enzyme Inhibitors; Humans; Melanoma, Experimental; Metabolic Networks and Pathways; Mice; Mice, Inbred C57BL; Pyruvates; Reactive Oxygen Species; Skin; Skin Neoplasms; Spheroids, Cellular; Treatment Outcome	2018

Article

Year

Topical 3-bromopyruvate is a novel targeted therapy for melanoma in a preclinical model.

Journal of dermatological science, 2018, Volume: 92, Issue:2

Topics: Administration, Cutaneous; Animals; Apoptosis; Cell Line, Tumor; Drug Evaluation, Preclinical; Enzyme Inhibitors; Humans; Melanoma, Experimental; Metabolic Networks and Pathways; Mice; Mice, Inbred C57BL; Pyruvates; Reactive Oxygen Species; Skin; Skin Neoplasms; Spheroids, Cellular; Treatment Outcome

2018